EQT VII acquires Certara for $850M
The EQT VII fund has agreed to acquire Certara, a provider of technology-driven decision support solutions for drug development, for an enterprise value of $850 million. The company is being acquired from Arsenal Capital Partners. As part of the transaction, Arsenal Capital Partners will retain a minority ownership stake in Certara, with the Company's current management team, led by Edmundo Muniz, M.D., Ph.D., continuing to lead the organization, building on a multi-year track record of both organic growth and strategic acquisitions.
Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara's solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, productivity and commercial challenges facing the biopharma industry. The Company serves 1,200 commercial companies, 250 academic institutions and numerous regulatory agencies, across 60 countries. Certara is headquartered in Princeton, New Jersey with over 500 employees globally, including key operations and senior management in Northern Europe.
Eric Liu, Partner at EQT Partners, Investment Advisor to EQT VII said: "We are deeply impressed by what the Certara management team has accomplished over the last few years. Today, Certara is the global leader in an exciting and rapidly developing market, uniquely positioned to transform the field of drug development. Under Edmundo's leadership the Company has assembled a strong and visionary management team and a highly-talented scientific staff, while fostering a mission-driven culture and accelerating growth. We are excited to support the development of Certara through continued investment in next generation technology, further international expansion and complementary acquisitions."
"We are excited to team up with EQT as we look toward Certara's next phase of growth," said Edmundo Muniz, M.D., Ph.D., and CEO of Certara. "This new strategic partnership with EQT will enable us to strengthen our core offerings as well as to capitalize on transformative next-phase growth opportunities. We are looking forward to a great partnership that will benefit our customers, our employees, and our industry."